Woo H, Kwon T, Heo S, Yoo J, Kim M, Oh J
BMC Infect Dis. 2025; 25(1):274.
PMID: 40001073
PMC: 11863440.
DOI: 10.1186/s12879-025-10661-8.
Ulu K, Caglayan S, Coskuner T, Vazgecer E, Oner T, Sozeri B
Pediatr Cardiol. 2025; .
PMID: 39875620
DOI: 10.1007/s00246-025-03785-w.
Habenbacher M, Moser U, Abaira A, Kiss P, Holzmeister C, Pock J
Pharmaceutics. 2024; 16(11).
PMID: 39598494
PMC: 11597114.
DOI: 10.3390/pharmaceutics16111370.
Guo L, Wang J, Li J, Yao J, Zhao H
Front Immunol. 2024; 15:1455346.
PMID: 39534599
PMC: 11554464.
DOI: 10.3389/fimmu.2024.1455346.
Bozkus F, Keskin O
J Clin Med. 2024; 13(19).
PMID: 39407934
PMC: 11477896.
DOI: 10.3390/jcm13195874.
A predictive model to explore risk factors for severe COVID-19.
Qian F, Cao Y, Liu Y, Huang J, Zhu R
Sci Rep. 2024; 14(1):18197.
PMID: 39107340
PMC: 11303808.
DOI: 10.1038/s41598-024-68946-y.
The oncogenic kinase TOPK upregulates in psoriatic keratinocytes and contributes to psoriasis progression by regulating neutrophils infiltration.
Zeng F, Du S, Wu M, Dai C, Li J, Wang J
Cell Commun Signal. 2024; 22(1):386.
PMID: 39090602
PMC: 11292866.
DOI: 10.1186/s12964-024-01758-9.
Blood-Count-Derived Inflammatory Markers as Predictors of Response to Biologics and Small-Molecule Inhibitors in Psoriasis: A Multicenter Study.
Morariu S, Cotoi O, Tiuca O, Baican A, Gheuca-Solovastru L, Decean H
J Clin Med. 2024; 13(14).
PMID: 39064032
PMC: 11277525.
DOI: 10.3390/jcm13143992.
The association between the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio and systemic sclerosis and its complications: a systematic review and meta-analysis.
Zinellu A, Mangoni A
Front Immunol. 2024; 15:1395993.
PMID: 38799443
PMC: 11116674.
DOI: 10.3389/fimmu.2024.1395993.
Associations of novel complete blood count-derived inflammatory markers with psoriasis: a systematic review and meta-analysis.
Liu Y, Chuang S, Chen Y, Shih Y
Arch Dermatol Res. 2024; 316(6):228.
PMID: 38787437
DOI: 10.1007/s00403-024-02994-2.
Evaluation of the inflammatory parameters as potential biomarkers of systemic inflammation extent and the disease severity in psoriasis patients.
Zhang Y, Qian H, Kuang Y, Wang Y, Chen W, Zhu W
Arch Dermatol Res. 2024; 316(6):229.
PMID: 38787405
DOI: 10.1007/s00403-024-02972-8.
Role of Hematological Indices as Predictors of Systemic Inflammation in Dermatology.
Aiholli S, Adya K, Inamadar A
Indian Dermatol Online J. 2024; 15(2):188-195.
PMID: 38550825
PMC: 10969267.
DOI: 10.4103/idoj.idoj_189_23.
Association between systemic immune-inflammation index and psoriasis: a population-based study.
Zhao X, Li J, Li X
Front Immunol. 2024; 15:1305701.
PMID: 38504983
PMC: 10948528.
DOI: 10.3389/fimmu.2024.1305701.
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in psoriasis: a systematic review and meta-analysis.
Ye J, Zhang Y, Naidoo K, Ye S
Arch Dermatol Res. 2024; 316(3):85.
PMID: 38329632
DOI: 10.1007/s00403-024-02823-6.
The diagnostic role of the systemic inflammation index in patients with immunological diseases: a systematic review and meta-analysis.
Mangoni A, Zinellu A
Clin Exp Med. 2024; 24(1):27.
PMID: 38285324
PMC: 10824868.
DOI: 10.1007/s10238-024-01294-3.
Impact of Blood-Count-Derived Inflammatory Markers in Psoriatic Disease Progression.
Tiuca O, Morariu S, Mariean C, Tiuca R, Nicolescu A, Cotoi O
Life (Basel). 2024; 14(1).
PMID: 38255729
PMC: 10820213.
DOI: 10.3390/life14010114.
Association between the neutrophil-to-lymphocyte ratio and psoriasis: a cross-sectional study of the National Health and Nutrition Examination Survey 2011-2014.
Hong J, Lian N, Li M
BMJ Open. 2023; 13(12):e077596.
PMID: 38149420
PMC: 10711904.
DOI: 10.1136/bmjopen-2023-077596.
A simple tool for evaluation of inflammation in psoriasis: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as markers in psoriasis patients and related murine models of psoriasis-like skin disease.
Kommoss K, Bieler T, Ringen J, Lehmann A, Mihalceanu S, Hobohm L
J Mol Med (Berl). 2023; 102(2):247-255.
PMID: 38127137
PMC: 10857970.
DOI: 10.1007/s00109-023-02406-4.
The Relationship of Hematological Parameters and C-reactive Protein (CRP) With Disease Presence, Severity, and Response to Systemic Therapy in Patients With Psoriasis.
Sener G, Yuksel E, Gokdeniz O, Karaman K, Canat H
Cureus. 2023; 15(8):e43790.
PMID: 37731441
PMC: 10507996.
DOI: 10.7759/cureus.43790.
Cellular Mechanisms of Psoriasis Pathogenesis: A Systemic Review.
Wu M, Dai C, Zeng F
Clin Cosmet Investig Dermatol. 2023; 16:2503-2515.
PMID: 37727872
PMC: 10506593.
DOI: 10.2147/CCID.S420850.